Pullease

Merck, Schering-Plough: Confessions of a Vytorin Patient

I concur with WaneNet, as I have an almost exact historical experience. It lowered my bad numbers, raised my good ones and lowered my triglycerides. NONE of the other statins did any good for me. I've never heard of plaque removal as the benchmark for success in any of the other drugs. I bought size in the convertible preferred after it collapsed at ~ 150. I'll get > 9% yield, and most of the upside as this gets worked out. I would also point out that a takeover is a distinct probability. They have one of the best pipelines / stock price extant. Shorts will get creamed on this one.